LGZG could also alleviate NAFLD through inhibiting PPP1R3C expression to reduce glycogen synthase activity, promoting glycogen phosphorylase, and reducing glycogen storage [70]. This evidence concerns the gene PPP1R3C and metabolic dysfunction-associated steatotic liver disease.